Market Overview The Precision Diagnostics Market is significantly advanced by liquid biopsy technology, which enables molecular analysis through minimally invasive blood sampling rather than tissue biopsy. This approach detects circulating tumor DNA, circulating tumor cells, exosomes, and other biomarkers shed into the bloodstream by diseased tissues. Liquid biopsies offer advantages including...